Nate Doran

Business Director

Seattle, Washington, United States

About

Nate has played an active role in Seattle's venture and angel communities since 2011, as a fund manager, as an angel group operator, as a board director/observer for several companies, and as an entrepreneur. Nate contributes his strategic expertise through mentoring entrepreneurs in achieving traction and in the fundraising process, and through this process, identifies companies that can yield a return for his LP's. Nate is the Business Director at Swan Venture Fund. Over the life of the funds, he has sourced, filtered, and led companies and due diligence teams through the investment process: in due diligence, investment review committees, term negotiations, and closing. He has raised capital in three funds. Specialties: Venture Capital, Investment Operations, Fund Management, Angel Investing, Angel Fund Management, Alternatives, Entrepreneurship, Startups, Startup Finance, Screening, Startup Due Diligence, Company Evaluation, Leadership, Marketing Strategy, Market Research, Market Analysis, Project Management, Business Development, Data Analysis, Statistics, Ethnography, Vim, SQL, Python, Pitchbook, Automation

Experience

  • Board Observer at APIContext
    May 2024 - Present · 2 yrs 3 mos

  • Board Member at Bold Reuse
    Mar 2023 - Present · 3 yrs 5 mos

    Bold Reuse sells end-to-end reusable packaging programs to help customers eliminate waste, build customer loyalty, and reduce costs.

  • Member at Sybilla Masters Fund
    Aug 2022 - Present · 4 yrs

    Mastersfund is in its 2nd fund and invests in pre-seed and seed stage, women-led, tech companies with sales.

  • Business Director at SWAN Venture Fund
    Jan 2015 - Present · 11 yrs 7 mos

    SWAN Venture Fund is a series of Seattle-based angel investor funds.

  • Board Observer at CurvaFix, Inc.
    Jan 2018 - Jun 2023 · 5 yrs 6 mos

    Curvafix is a a medical device company focused on an unmet need for fixation of curved bones in orthopedic trauma. Curvafix received U.S. FDA clearance for its device and is currently conducting the RESTORE Study focused on gathering clinical evidence in advance of commercial launch. www.curvafix.com